Influence of Everolimus on Cyclosporine Neoral Pharmacokinetics in Chinese de Novo Cardiac Transplant Recipients

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2032-2034

  Wang, C H ^a   Chou, N K ^a   Wu, F L L ^b   Ko, W J ^a   Tsao, C I ^a   Chi, N H ^a   Hsu, R B ^a   Wang, S S ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; THYMOCYTE ANTIBODY;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; RECIPIENT; STEADY STATE;

ADULT; AZATHIOPRINE; CHINA; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SIROLIMUS;

EID: 33846045141     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.038     Document Type: Article

References (5)

1. Eisen H.J., Tuzcu M.T., and Dorent R. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847
2. Kovarik J.M., Eisen H., and Dorent R. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. J Heart Lung Transplant 22 (2003) 1117
3. Kovarik J.M., Kaplan B., and Silva H.T. Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation. Am J Transplant 3 (2003) 606
4. Chien N.C., Lin F.L., and Chou N.K. Rabbit antithymocyte globulin induction immunosuppression in heart transplantation. Transplant Proc 32 (2000) 2380
5. Wang C.H., Ko W.J., and Chou N.K. A limited sampling strategy for the estimation of 12-hour cyclosporine Neoral area under the curve in Chinese cardiac transplant recipients. Transplant Proc 36 (2004) 2390